Belite Bio, Inc. ADR's market cap is currently $2.90B. The company's EPS TTM is $-0.5; its P/E ratio is ―; Belite Bio, Inc. ADR is scheduled to report earnings on August 11, 2025, and the estimated EPS forecast is $-0.49. See an overview of income statement, balance sheet, and cash flow financials.
